<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-08-20T15:40:57Z</responseDate><request verb="GetRecord" identifier="oai:docta.ucm.es:20.500.14352/122854" metadataPrefix="oai_dc">https://docta.ucm.es/rest/oai/request</request><GetRecord><record><header><identifier>oai:docta.ucm.es:20.500.14352/122854</identifier><datestamp>2025-07-30T00:08:53Z</datestamp><setSpec>com_20.500.14352_14</setSpec><setSpec>col_20.500.14352_15</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
   <dc:title>Design and sustainable synthesis of small mannose-based glycodendrons as ligands for HIV-1 envelope protein gp120: Toward an explanation for their binding</dc:title>
   <dc:creator>Perona Requena, Almudena</dc:creator>
   <dc:creator>Ramírez López, Pedro</dc:creator>
   <dc:creator>Suárez Álvarez, José Ramón</dc:creator>
   <dc:creator>Hernáiz Gómez-Degano, María Josefa</dc:creator>
   <dc:creator>Martínez Espinosa, Carlos Antonio</dc:creator>
   <dc:creator>Merchán, Alejandro</dc:creator>
   <dc:subject>615:54</dc:subject>
   <dc:subject>615.31</dc:subject>
   <dc:subject>612.396</dc:subject>
   <dc:subject>577.114</dc:subject>
   <dc:subject>578</dc:subject>
   <dc:subject>612.017</dc:subject>
   <dc:subject>Glycodendrons</dc:subject>
   <dc:subject>Glycodendrimers</dc:subject>
   <dc:subject>Click chemistry</dc:subject>
   <dc:subject>Immunodeficiency virus</dc:subject>
   <dc:subject>HIV-1 gp120 binders</dc:subject>
   <dc:subject>Carbohydrate-protein interactions</dc:subject>
   <dc:subject>Ciencias</dc:subject>
   <dc:subject>Ciencias Biomédicas</dc:subject>
   <dc:subject>Química</dc:subject>
   <dc:subject>Química orgánica (Química)</dc:subject>
   <dc:subject>Química farmaceútica</dc:subject>
   <dc:subject>Farmacia</dc:subject>
   <dc:subject>Biología</dc:subject>
   <dc:subject>24 Ciencias de la Vida</dc:subject>
   <dc:subject>23 Química</dc:subject>
   <dc:subject>3303.05 Síntesis Química</dc:subject>
   <dc:subject>2306.06 Química de Los Hidratos de Carbono</dc:subject>
   <dc:subject>2420 Virología</dc:subject>
   <dc:subject>2412 Inmunología</dc:subject>
   <dc:description>The 1H NMR and 13C NMR spectra were carried out at CAI Unidad de Resonancia Magnética (UCM). The authors gratefully acknowledge financial support provided by the Spanish Ministerio de Ciencia e Innovacion, ´ Grants RTI2018-096037B-I00, TED2021-130430B-C21, and PDC2022-133817-I00.</dc:description>
   <dc:description>On the basis of the interesting properties that glucuronic acid-based glycodendrimers and glycodendrons show  against Dengue virus through their interaction with its envelope protein, herein we describe the design, sustainable synthesis and anti HIV-1 evaluation of a series of mannose-based glycodendrimers bearing different scaffolds, valency and functional groups at the focal position. Their sustainable chemical synthesis was performed using microwave-assisted copper(I) catalyzed azide-alkyne cycloaddition (CuAAC) reaction to yield  glycoconjugates with full conversions (99%), allowing the reduction of the reaction time from 16 h to 60–120 min. Surface plasmon resonance studies have demonstrated that the small mannose-based glycodendrons  (divalent derivatives) give the best binding interactions with the HIV-1 gp120 envelope protein, being the most active those that have a methoxymethyl group or an azidomethyl group at the focal position. Molecular modeling studies were carried out to simulate and explain the binding observed by surface plasmon resonance. This work reports a sustainable synthesis of small mannose-based glycodendrons as novel and potent anti HIV lead compounds.</dc:description>
   <dc:description>Ministerio de Cienca e Innovación (España)</dc:description>
   <dc:description>Depto. de Química en Ciencias Farmacéuticas</dc:description>
   <dc:description>Fac. de Farmacia</dc:description>
   <dc:description>TRUE</dc:description>
   <dc:description>pub</dc:description>
   <dc:date>2025-07-29T12:16:41Z</dc:date>
   <dc:date>2025-07-29T12:16:41Z</dc:date>
   <dc:date>2024</dc:date>
   <dc:type>journal article</dc:type>
   <dc:type>VoR</dc:type>
   <dc:identifier>https://hdl.handle.net/20.500.14352/122854</dc:identifier>
   <dc:identifier>XXXX-XXXX</dc:identifier>
   <dc:identifier>10.1016/j.cattod.2023.114493</dc:identifier>
   <dc:language>eng</dc:language>
   <dc:relation>info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/RTI2018-096037B-I00</dc:relation>
   <dc:relation>info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023/PDC2022-133817-I00/ES/BIOPRODUCION DE BIOSURFACTANTES CON APLICACION EN LA INDUSTRIA COSMETICA Y FARMACEUTICA: APROXIMACION SOSTENIBLE/</dc:relation>
   <dc:relation>Carlos Martínez, Alejandro Merchán, Almudena Perona, Pedro Ramírez-López, José Ramón Suárez, María J. Hernáiz, Design and sustainable synthesis of small mannose-based glycodendrons as ligands for HIV-1 envelope protein gp120: Toward an explanation for their binding, Catalysis Today, Volume 429, 2024, 114493,</dc:relation>
   <dc:rights>restricted access</dc:rights>
   <dc:format>application/pdf</dc:format>
   <dc:publisher>Elsevier</dc:publisher>
</oai_dc:dc></metadata></record></GetRecord></OAI-PMH>